Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Attempts to predict the long-term decrease in lung function due to radiotherapy of non-small cell lung cancer.

Morten Nielsen1, Olfred Hansen, Werner Vach

  • 1Radiofysisk Laboratorium, Odense University Hospital, Denmark. morten.nielsen@ouh.fyns-amt.dk

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment.

Frontiers in immunology·2026
Same author

Cancer epitope prediction tools and analysis pipelines in CEDAR.

Nucleic acids research·2026
Same author

NetMHCIIphosPan: A Machine Learning Tool for Predicting HLA Class II Antigen Presentation of Phosphorylated Peptides.

Journal of proteome research·2026
Same author

Standardising image registration and dose mapping for thoracic reirradiation: A national multi-centre benchmarking study.

Physics and imaging in radiation oncology·2026
Same author

NetMHCIIphosPan: a machine learning tool for predicting HLA class II antigen presentation of phosphorylated peptides.

bioRxiv : the preprint server for biology·2026
Same author

Integrated computational and experimental workflow identifies a novel T-cell epitope from Babesia bovis RON5 recognized by infected cattle.

Vaccine·2025
Same journal

Pre-treatment PSQA - Do we still need to measure and what are adequate alternatives?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Dosimetric verification of every treatment plan: Do or not to do?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Pre-treatment PSQA - Do we still need to measure and what are adequate alternatives?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Pre-treatment PSQA - Do we still need to measure and what are adequate alternatives? Optimizing PSQA in radiotherapy workflows through commissioning and standardized treatment planning with class solutions.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Pre-treatment PSQA - Do we still need to measure and what are adequate alternatives?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
See all related articles

This study developed a model to predict long-term lung function decline after radiation therapy for non-small cell lung cancer patients. A dose-volume model effectively predicted FEV1 decrease, considering measurement uncertainty.

Area of Science:

  • Radiation Oncology
  • Pulmonary Medicine
  • Medical Physics

Background:

  • Radiation therapy for non-small cell lung cancer (NSCLC) can cause long-term lung damage.
  • Predicting this lung function decrease is crucial for patient management and treatment planning.

Purpose of the Study:

  • To develop a predictive model for long-term lung function decline (FEV1) after radiation therapy.
  • To correlate radiation dose-volume data with observed FEV1 reduction in NSCLC patients.

Main Methods:

  • Analyzed data from 27 long-term survivors of radical radiation therapy for NSCLC.
  • Used regression analysis to estimate FEV1 decrease and standard error (SE) over 2 years.
  • Modeled lung function using dose-volume histograms (DVH), including threshold, mean lung dose, and relative damaged volume (rdV) models.

Related Experiment Videos

Main Results:

  • Observed median FEV1 decrease of 10% (up to 28%) after 2 years, with significant patient-specific variation.
  • Threshold models showed good prediction when SE represented measurement uncertainty; best threshold was 30 Gy (R²=0.46).
  • A model based on relative damaged volume (rdV) outperformed others (R²=0.52).

Conclusions:

  • Long-term FEV1 decrease in NSCLC patients can be predicted using a dose-volume model.
  • Incorporating measurement uncertainty (SE) improves the accuracy of these predictive models.